Quality of life outcomes of ECT

Research output: Chapter in Book/Report/Conference proceedingChapter


Electroconvulsive therapy (ECT) continues to stand the test of time. There is a growing demand for patient reported outcome data including measures of HRQL, patient satisfaction and utility. ECT is efficacious for a number of psychiatric conditions but it is often reserved for the most ill patients because compared to drugs or psychotherapy it has a higher cost per unit of treatment, requires anesthesia, and because of a continuing stigma. As well, ECT has a particular set of side effects including the potential for memory impairment, and cardiac death. Mental illness produces profound deficits in HRQL and loss of HRQL is linear to severity of illness, and may therefore be part of decision to refer for ECT. At baseline studies have shown that ECT patients have reduced HRQL and functioning. ECT treatment improves HRQL and functioning in a lasting way for patients with major depression and schizophrenia. HRQL improvements are related to ECT's effect on mood whereas functional improvements are more closely related to cognition

Original languageEnglish (US)
Title of host publicationQuality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders
Subtitle of host publicationNew Perspectives on Research and Treatment
PublisherSpringer Netherlands
Number of pages11
ISBN (Print)9781402057779
StatePublished - 2007
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Quality of life outcomes of ECT'. Together they form a unique fingerprint.

Cite this